APOTEX INC, — Ramipril Importer Profile
Pharmaceutical Importer · #10 buyer for Ramipril · $1.4M import value · 45 shipments · CANADA · DGFT Verified
APOTEX INC, is the #10 importer of Ramipril from India with $1.4M in import value and 45 verified shipments. APOTEX INC, holds a 2.0% market share in Ramipril imports based in CANADA. The company sources from 1 verified supplier across 41 formulations shipped to 1 country. Overall, APOTEX INC, imports 14 pharmaceutical products worth $40.9M across 7 therapeutic categories.
APOTEX INC, — Ramipril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ramipril to APOTEX INC,?
Verified from 45 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| APOTEX RESEARCH PRIVATE LIMITED | $1.4M | 45 | 100.0% |
APOTEX INC, sources Ramipril from 1 verified Indian supplier based on 45 customs records. The primary supplier is APOTEX RESEARCH PRIVATE LIMITED accounting for 100.0% of imports.
How Does APOTEX INC, Compare to Nearest Ramipril Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MILPHARM LIMITED, | UNITED KINGDOM | $2.6M | 52 | $50.0K |
| 1 | CSP VIATRIS SANTE AT CSP- LAB, | FRANCE | $2.2M | 44 | $50.0K |
| 10 | APOTEX INC, ★ | CANADA | $1.8M | 45 | $40.5K |
| 11 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $1.8M | 143 | $12.7K |
| 12 | CRESCENT PHARMA LIMITED. | UNITED KINGDOM | $1.5M | 81 | $19.1K |
APOTEX INC, ranks #10 among 389 Ramipril importers from India. Average shipment value of $40.5K compared to the market average of $102.1K. The closest competitors by value are MILPHARM LIMITED, and CSP VIATRIS SANTE AT CSP- LAB,.
Where Does APOTEX INC, Import Ramipril To?
Destination countries from 45 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.4M | 45 | 100.0% |
APOTEX INC, imports Ramipril to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.4M.
What Ramipril Formulations Does APOTEX INC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO-RAMIPRIL CAP 10MG 500 BTL 47490 / 771313171366-VJ6697 | $100.0K | 2 |
| RAMIPRIL CAP 5 MG 100 BTL SIV 66470 / 628003006364-VJ6588 | $100.0K | 2 |
| RAMIPRIL CAP 10MG 500 BTL SIV 66474 / 628003006401-VJ6696 | $62.7K | 2 |
| APO-RAMIPRIL CAP SMG 500 BTL 47496 / 771313171427-VG5874 | $50.0K | 1 |
| APO-RAMIPRIL CAP 10MG 500 BTL 47490 / 771313171366-VG5896 | $50.0K | 1 |
| APO-RAMIPRIL CAP 10MG 500 BTL 47490 / 771313171366-VG5908 | $50.0K | 1 |
| RAMIPRIL CAP SMG 100 BTL SIV 66470 / 628003006364-VH5312 | $50.0K | 1 |
| RAMIPRIL CAP SMG 500 BTL SIV 66471 / 628003006371-VH5313 | $50.0K | 1 |
| RAMIPRIL CAP 5 MG 100 BTL SIV 66470 / 628003006364-VH5312 | $50.0K | 1 |
| RAMIPRIL CAP 5 MG 500 BTL SIV 66471 / 628003006371-VH5313 | $50.0K | 1 |
APOTEX INC, imports 41 distinct Ramipril formulations from India. The top formulation is APO-RAMIPRIL CAP 10MG 500 BTL 47490 / 771313171366-VJ6697 with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Ramipril into Canada
What APOTEX INC, and other importers must comply with to import Ramipril from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Ramipril
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ramipril from India and How Much Does APOTEX INC, Import?
India exported $39.7M worth of Ramipril through 4,977 shipments from 177 suppliers to 93 countries, serving 389 buyers globally. APOTEX INC, imports $1.4M of this total, accounting for 2.0% of India's Ramipril exports with 45 shipments from CANADA. This is verified from 45 customs shipment records covering 41 distinct formulations.
What Is the Average Order Value for APOTEX INC,'s Ramipril Imports?
APOTEX INC,'s average Ramipril order value is $30.9K per consignment, based on 45 shipments totaling $1.4M. APOTEX INC, is based in CANADA and ranks #10 among all Ramipril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ramipril to APOTEX INC,?
APOTEX INC, sources Ramipril from 1 verified Indian supplier: APOTEX RESEARCH PRIVATE LIMITED ($1.4M, 100.0%). This is based on 45 customs records.
How Does APOTEX INC, Compare to Other Ramipril Importers?
APOTEX INC, ranks #10 among 389 Ramipril importers from India with a 2.0% market share. The top 3 importers are WOCKHARDT UK LIMITED ($6.7M), CRESCENT PHARMA LTD ($5.8M), BROWN AND BURK UK LIMITED ($4.0M). APOTEX INC, processed 45 shipments from CANADA.
What Other Cardiovascular Products Does APOTEX INC, Import?
APOTEX INC, also imports these cardiovascular products. Each links to the detailed product page.
About APOTEX INC,
APOTEX INC, imports 14 products worth $40.9M. Beyond Ramipril, top products include Apixaban, Fluticasone, Atorvastatin, Amino, Acetaminophen. View the complete APOTEX INC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ramipril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC,'s capped import value divided by total capped export value for Ramipril across all Indian exporters.
- 5.Verified Records: This page is backed by 45 individual customs records matching APOTEX INC, importing Ramipril, covering 41 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 93+ countries, 389+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ramipril Import Data for APOTEX INC,
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC,'s Ramipril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC,
Full Company Profile →
14 products · $40.9M total trade · 7 categories
APOTEX INC, × Ramipril
Verified from customs records
Company Overview
Top Products by APOTEX INC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ramipril. For current order-level data, contact TransData Nexus.